Skip to Main Content

Paper Details

Targeting Isocitrate Dehydrogenase Mutations in Cancer: Emerging Evidence and Diverging Strategies.
Clinical Cancer Research
11
2021
Cancer, D-2-hydroxyglutarate, D-2HG, DNA, IDH, Isocitrate, Isocitrate Dehydrogenase Mutations, Isocitrate dehydrogenase, anticancer, cancers, glioma, gliomas, histone, histones, mutant, mutant IDH, mutant IDH1, progenitor cells
Author NameAffiliation
Hai YanDuke University
Hai YanDuke University School of Medicine
  • 1 - 2

Datasets

Release 1.2